ELIZABETH FAGAN: Open Payments
NPI 1275195026 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| BeOne Medicines USA, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: SARCLISA, OPDIVO, ICLUSIG, LUTATHERA, DARZALEX, KEYTRUDA QLEX, DATROWAY, RYBREVANT.
Industry payments across NC — which companies pay providers there.
